Design and synthesis of pyrazole-oxindole conjugates targeting tubulin polymerization as new anticancer agents

被引:98
作者
Kamal, Ahmed [1 ]
Shaik, Anver Basha [1 ]
Jain, Nishant [2 ]
Kishor, Chandan [2 ]
Nagabhushana, Ananthamurthy [3 ,4 ]
Supriya, Bhukya [2 ]
Kumar, G. Bharath [1 ]
Chourasiya, Sumit S. [1 ]
Suresh, Yerramsetty [2 ]
Mishra, Rakesh K. [3 ]
Addlagatta, Anthony [2 ]
机构
[1] Indian Inst Chem Technol, CSIR, Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India
[2] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Hyderabad 500007, Andhra Pradesh, India
[3] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India
[4] IISER Pune, CoE Epigenet, Pune 411021, Maharashtra, India
关键词
Pyrazole-oxindole conjugates; Tubulin depolymerization; Zebrafish screening and molecular modeling; INHIBITORS; KINASE; COMPLEX; DRUGS;
D O I
10.1016/j.ejmech.2013.10.077
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of twenty one compounds with pyrazole and oxindole conjugates were synthesized by Knoe-venagel condensation and investigated for their antiproliferative activity on different human cancer cell lines. The conjugates are comprised of a four ring scaffold; the structural isomers 12b and 12c possess chloro-substitution in the D ring. Among the congeners 12b, 12c, and 12d manifested significant cytotoxicity and inhibited tubulin assembly. Treatments with 12b, 12c and 12d resulted in accumulation of cells in G2/M phase, disruption of microtubule network, and increase in cyclin B1 protein. Zebrafish screening revealed that 12b, and 12d caused developmental defects. Docking analysis demonstrated that the congeners occupy the colchicine binding pocket of tubulin. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:501 / 513
页数:13
相关论文
共 28 条
  • [1] Tri- and Tetrasubstituted Pyrazole Derivates: Regioisomerism Switches Activity from p38MAP Kinase to Important Cancer Kinases
    Abu Thaher, Bassam
    Arnsmann, Martina
    Totzke, Frank
    Ehlert, Jan E.
    Kubbutat, Michael H. G.
    Schaechtele, Christoph
    Zimmermann, Markus O.
    Koch, Pierre
    Boeckler, Frank M.
    Laufer, Stefan A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 961 - 965
  • [2] Synthesis, in silico, in vitro, and in vivo investigation of 5-[11C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2
    Caballero, Julio
    Munoz, Camila
    Alzate-Morales, Jans H.
    Cunha, Susana
    Gano, Lurdes
    Bergmann, Ralf
    Steinbach, Joerg
    Kniess, Torsten
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 58 : 272 - 280
  • [3] Preface
    Chen, Jing
    Lemyre, Louise
    Wilkins, Ruth
    Wilkinson, Diana
    [J]. RADIATION PROTECTION DOSIMETRY, 2010, 142 (01) : 1 - 1
  • [4] DeLano W.L., 2002, DeLano Scientific LLC
  • [5] Microtubule-binding agents: a dynamic field of cancer therapeutics
    Dumontet, Charles
    Jordan, Mary Ann
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (10) : 790 - 803
  • [6] Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
    Hoessel, R
    Leclerc, S
    Endicott, JA
    Nobel, MEM
    Lawrie, A
    Tunnah, P
    Leost, M
    Damiens, E
    Marie, D
    Marko, D
    Niederberger, E
    Tang, WC
    Eisenbrand, G
    Meijer, L
    [J]. NATURE CELL BIOLOGY, 1999, 1 (01) : 60 - 67
  • [7] Microtubules as a target for anticancer drugs
    Jordan, MA
    Wilson, L
    [J]. NATURE REVIEWS CANCER, 2004, 4 (04) : 253 - 265
  • [8] How do microtubule-targeted drugs work? An overview
    Jordan, Mary Ann
    Kamath, Kathy
    [J]. CURRENT CANCER DRUG TARGETS, 2007, 7 (08) : 730 - 742
  • [9] Synthesis and anticancer activity of heteroaromatic linked 4β-amido podophyllotoxins as apoptotic inducing agents
    Kamal, Ahmed
    Tamboli, Jaki R.
    Vishnuvardhan, M. V. P. S.
    Adil, S. F.
    Nayak, V. Lakshma
    Ramakrishna, S.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (01) : 273 - 280
  • [10] Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines
    Kamal, Ahmed
    Ramakrishna, G.
    Raju, P.
    Rao, A. V. Subba
    Viswanath, A.
    Nayak, V. Lakshma
    Ramakrishna, Sistla
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (06) : 2427 - 2435